Flint, Mich. –Jan. 8, 2014 — Diplomat, the country’s largest independent specialty pharmacy, announced today that CEO and co-founder Phil Hagerman, R.Ph. and Diplomat CFO Sean Whelan, CPA, will be co-presenters at J.P. Morgan’s 32nd Annual Healthcare Conference, to be held Jan. 13-16 in San Francisco.

Hagerman and Whelan are scheduled to speak on Tuesday, Jan. 14 at 3:30 p.m. PT and will highlight growth opportunities within the rapidly expanding specialty pharmacy industry, as well as specific company developments. This is the second consecutive year Diplomat has been invited by J.P. Morgan to present on the private company track at the invitation-only conference, considered the nation’s premier healthcare investment symposium.

Diplomat serves patients and physicians in all 50 states as the nation’s largest independent specialty pharmacy. Headquartered in Flint, Mich., the company focuses on medication management programs for people with specialized or long-term medical needs, including cancer, HIV, Hepatitis C, multiple sclerosis and other serious and chronic conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues — always focused on increasing adherence and improving outcomes. Diplomat is accredited by URAC, PCAB, VAWD, ASHP and ACHC.

Media Contact: Barbara Fornasiero, EAFocus Communications: 248.651.7536; Cell: 586.817.8414; barbara@eafocus.com. Jim Kosmerick, Diplomat: 810.768.9530; JKosmerick@diplomatpharmacy.com.

Twitter